CIRM Funded Clinical Trials
Advancing ISP-001 for Mucopolysaccharidosis I: Clinical Expansion, Clinical Manufacturing and Release Testing
Disease Area:
Genetic Disorder, Metabolic Disorders, Other, Pediatrics
Trial Sponsor:
Immusoft Corporation
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A